| 200806-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
≥95%,99%e.e.
|
100MG |
C60H85F3NO11PS |
|
|
|
| 200758-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
≥95%,99%e.e.
|
100MG |
C60H85F3NO11PS |
|
|
|
| 200805-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
≥95%,99%e.e.
|
100MG |
C48H61F3NO7PS |
|
|
|
| 200757-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-hydroxy-2,2-dimethyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine-6-yl)methanesulfonamide
≥95%,99%e.e.
|
100MG |
C48H61F3NO7PS |
|
|
|
| 200804-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aS,8aS)-4,4,8,8-tetra-2-naphthalenyl-6-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)methanesulfonamide
≥95%,99%e.e.
|
100MG |
C48H37F3NO7PS |
|
|
|
| 200756-100MG |
|
NA |
1,1,1-Trifluoro-N-(3aR,8aR)-4,4,8,8-tetra-2-naphthalenyl-6-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)methanesulfonamide
≥95%,99%e.e.
|
100MG |
C48H37F3NO7PS |
|
|
|
| 200803-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetra-9-phenanthrenel-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin
≥95%,99%e.e.
|
100MG |
C63H45O6P |
|
|
|
| 200779-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetra-9-phenanthrenel-tetrahydro-6-hydroxy-2,2-dimethyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin
≥95%,99%e.e.
|
100MG |
C63H45O6P |
|
|
|
| 200802-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H101O6P |
|
|
|
| 200802-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H101O6P |
|
|
|
| 200778-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H101O6P |
|
|
|
| 200778-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-o-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H101O6P |
|
|
|
| 200801-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H101O6P |
|
|
|
| 200801-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H101O6P |
|
|
|
| 200777-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H101O6P |
|
|
|
| 200777-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-m-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H101O6P |
|
|
|
| 200800-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H101O6P |
|
|
|
| 200800-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H101O6P |
|
|
|
| 200776-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H101O6P |
|
|
|
| 200776-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H101O6P |
|
|
|
